## **Core Concept**
Estrogen therapy in postmenopausal women can have various effects on the body, including impacts on the cardiovascular system, breast tissue, and endometrium. The use of estrogen, particularly unopposed estrogen (estrogen without progesterone), is known to have several risks associated with it.

## **Why the Correct Answer is Right**
The correct answer, , suggests that the risk of a particular condition is not increased with estrogen therapy. Typically, estrogen therapy can increase the risk of breast cancer (B), endometrial cancer (A), and possibly venous thromboembolism (D). However, the effect of estrogen on osteoporosis and fractures is generally protective, reducing the risk.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Endometrial cancer risk is increased with unopposed estrogen therapy. The addition of progesterone (combined hormone therapy) mitigates this risk.
- **Option B:** Breast cancer risk has been shown to be increased with combined estrogen and progesterone therapy, though the risk may be more related to the addition of progesterone.
- **Option D:** Venous thromboembolism risk is increased with estrogen therapy, which is a well-documented side effect.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that estrogen therapy, especially when used alone (unopposed) in postmenopausal women, significantly increases the risk of endometrial cancer. However, the risk of osteoporosis and related fractures is decreased with estrogen therapy. This protective effect on bone density is one reason estrogen therapy might be considered for certain postmenopausal women, under specific circumstances.

## **Correct Answer:** . Decreased risk of osteoporosis.